Treatment of acute and chronic pancreatitis.
D000208:Acute Disease; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000430:Alcohol Withdrawal Delirium / Q000188:drug therapy; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D007611:Aprotinin / Q000627:therapeutic use; D001927:Brain Diseases / Q000188:drug therapy; D002446:Celiac Disease / Q000209:etiology; D002908:Chronic Disease; D003920:Diabetes Mellitus / Q000209:etiology; D005934:Glucagon / Q000627:therapeutic use; D006331:Heart Diseases / Q000209:etiology; D006801:Humans; D006996:Hypocalcemia / Q000209:etiology; D007231:Infant, Newborn; D007415:Intestinal Obstruction / Q000188:drug therapy; D007565:Jaundice / Q000209:etiology; D007674:Kidney Diseases / Q000209:etiology; D010146:Pain / Q000188:drug therapy; D010181:Pancreatic Cyst / Q000209:etiology; D010195:Pancreatitis / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D010276:Parasympatholytics / Q000627:therapeutic use; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy; D012709:Serum Albumin / Q000378:metabolism; D012769:Shock / Q000209:etiology; D014883:Water-Electrolyte Imbalance / Q000188:drug therapy
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D010276:Parasympatholytics; D012709:Serum Albumin; D005934:Glucagon; D007611:Aprotinin